GT Biopharma (GTBP) SEC Filings & 10K Form $1.82 +0.08 (+4.60%) As of 09:56 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent GT Biopharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView07/24/20253:34 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/03/20257:30 AMGT Biopharma (Filer)Form 424B307/02/202511:15 PMGT Biopharma (Filer)Form EFFECT06/27/20254:30 PMGT Biopharma (Filer)Form S-1/A06/11/20254:30 PMGT Biopharma (Filer)Form S-1Registration statement under Securities Act of 1933 06/11/20253:30 PMGT Biopharma (Filer)Form DEF 14A06/11/20253:31 PMGT Biopharma (Filer)Form DEFA14A06/02/20256:46 PMBRISTOL INVESTMENT FUND LTD (Filed by)GT Biopharma (Subject)Form SCHEDULE 13G/A05/29/20253:15 PMGT Biopharma (Issuer)Ritter Andrew J (Reporting)Form 3Initial statement of beneficial ownership of securities 05/27/20253:15 PMGT Biopharma (Filer)Form DNotice of Exempt Offering of Securities 05/27/20253:15 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/14/20258:22 AMFive Narrow Lane LP (Filed by)GT Biopharma (Subject)Form SCHEDULE 13G05/13/20258:01 AMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/14/20253:05 PMGT Biopharma (Filer)Form 10-K/A03/14/20258:00 AMGT Biopharma (Filer)Form 424B303/13/202511:15 PMGT Biopharma (Filer)Form EFFECT03/07/20254:29 PMGT Biopharma (Filer)Form DNotice of Exempt Offering of Securities 03/06/20254:20 PMGT Biopharma (Filer)Form S-3Registration statement under Securities Act of 1933 02/26/20254:07 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/24/20257:00 AMGT Biopharma (Filer)Form RW02/21/20254:01 PMGT Biopharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/07/20258:32 AMGT Biopharma (Filer)Form S-1/A01/27/20257:31 AMGT Biopharma (Filer)Form S-1/A01/27/20256:00 AMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/23/20244:23 PMGT Biopharma (Filer)Form S-1Registration statement under Securities Act of 1933 11/27/20243:05 PMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/21/20248:25 AMGT Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/21/20248:13 PMGT Biopharma (Issuer)URBAN ALAN LOUIS (Reporting)Form 4Statement of changes in beneficial ownership of securities 10/17/202410:15 AMCYTOVANCE BIOLOGICS INC (Filed by)GT Biopharma (Subject)Form SCHEDULE 13G/A(Data available from 1/1/2016 forward) Related Companies and Tools Related Companies NAII 10K Form RLYB 10K Form DARE 10K Form ELEV 10K Form AYTU 10K Form CLDI 10K Form LSTA 10K Form ATNF 10K Form ADAP 10K Form RVPH 10K Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:GTBP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
